OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $958,378 | -33.9% | 305,216 | +8.7% | 0.00% | – |
| Q2 2023 | $1,449,310 | -10.5% | 280,874 | -8.5% | 0.00% | – |
| Q1 2023 | $1,618,460 | +83.9% | 307,108 | -1.9% | 0.00% | – |
| Q4 2022 | $880,069 | -11.2% | 313,192 | +31.2% | 0.00% | – |
| Q3 2022 | $991,000 | -1.1% | 238,632 | -4.3% | 0.00% | – |
| Q2 2022 | $1,002,000 | -18.6% | 249,259 | +0.2% | 0.00% | – |
| Q1 2022 | $1,231,000 | -28.6% | 248,748 | +0.6% | 0.00% | – |
| Q4 2021 | $1,723,000 | +201.2% | 247,180 | +70.7% | 0.00% | – |
| Q4 2019 | $572,000 | -20.1% | 144,768 | -38.5% | 0.00% | – |
| Q3 2019 | $716,000 | -36.2% | 235,403 | -7.7% | 0.00% | – |
| Q2 2019 | $1,122,000 | -28.9% | 255,037 | -35.9% | 0.00% | – |
| Q1 2019 | $1,579,000 | -65.6% | 397,903 | -65.5% | 0.00% | -100.0% |
| Q4 2018 | $4,592,000 | -54.7% | 1,153,672 | -21.7% | 0.00% | -50.0% |
| Q3 2018 | $10,135,000 | -0.8% | 1,473,182 | -2.6% | 0.00% | 0.0% |
| Q2 2018 | $10,213,000 | +8.2% | 1,513,007 | +4.4% | 0.00% | 0.0% |
| Q1 2018 | $9,439,000 | +70.0% | 1,449,865 | +16.2% | 0.00% | +100.0% |
| Q4 2017 | $5,552,000 | -31.7% | 1,247,528 | -5.2% | 0.00% | -50.0% |
| Q3 2017 | $8,129,000 | -33.0% | 1,315,265 | +0.5% | 0.00% | -33.3% |
| Q2 2017 | $12,130,000 | -0.4% | 1,308,563 | -0.3% | 0.00% | 0.0% |
| Q1 2017 | $12,182,000 | +49.9% | 1,312,703 | +35.2% | 0.00% | +50.0% |
| Q4 2016 | $8,127,000 | +20.4% | 970,936 | -1.1% | 0.00% | 0.0% |
| Q3 2016 | $6,748,000 | +41.8% | 982,176 | +2.2% | 0.00% | +100.0% |
| Q2 2016 | $4,758,000 | -43.0% | 961,136 | +11.1% | 0.00% | -50.0% |
| Q1 2016 | $8,353,000 | -4.2% | 864,768 | -7.1% | 0.00% | 0.0% |
| Q4 2015 | $8,720,000 | -32.3% | 930,605 | +1.6% | 0.00% | -50.0% |
| Q3 2015 | $12,884,000 | -31.3% | 916,362 | +2.8% | 0.00% | -20.0% |
| Q2 2015 | $18,745,000 | -63.5% | 891,285 | -27.2% | 0.01% | -61.5% |
| Q1 2015 | $51,370,000 | +68.4% | 1,223,552 | -5.6% | 0.01% | +62.5% |
| Q4 2014 | $30,497,000 | +58.2% | 1,296,690 | +0.7% | 0.01% | +60.0% |
| Q3 2014 | $19,276,000 | – | 1,287,610 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |